Related references
Note: Only part of the references are listed.The Impact of Immune Cell-derived Exosomes on Immune Response Initiation and Immune System Function
Fataneh Tavasolian et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Effects of High Glucose and Lipotoxicity on Diabetic Podocytes
Ran Nakamichi et al.
NUTRIENTS (2021)
Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine
Wumei Wei et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
被撤回的出版物: BMSCs-derived exosomal microRNA-let-7a plays a protective role in diabetic nephropathy via inhibition of USP22 expression (Retracted article. See vol. 318, 2023)
Ruiyang Mao et al.
LIFE SCIENCES (2021)
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2021)
HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis
DongWei Liu et al.
CELL DEATH & DISEASE (2021)
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1
Yan Hao et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
The glomerular filtration barrier: a structural target for novel kidney therapies
Ilse S. Daehn et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Serum exosomes from diabetic kidney disease patients promote pyroptosis and oxidative stress through the miR-4449/HIC1 pathway
Chan Gao et al.
NUTRITION & DIABETES (2021)
Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model
Shunsuke Takemura et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
High Glucose Induces Mesangial Cell Apoptosis through miR-15b-5p and Promotes Diabetic Nephropathy by Extracellular Vesicle Delivery
Yi-Chun Tsai et al.
MOLECULAR THERAPY (2020)
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
Nik Nur Syazana Binti Nik Mohamed Kamal et al.
FRONTIERS IN PHARMACOLOGY (2020)
Exosomes: Effectual players in rheumatoid arthritis
Fataneh Tavasolian et al.
AUTOIMMUNITY REVIEWS (2020)
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
Jiarong Lv et al.
JOURNAL OF DIABETES RESEARCH (2020)
Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy
Yurui Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Circulating exosomalmicroRNAsas emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle
Runfa Zhou et al.
IUBMB LIFE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease
Yanyan Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
Christian Savio-Silva et al.
STEM CELLS INTERNATIONAL (2020)
Concise review: current trends on applications of stem cells in diabetic nephropathy
Dongwei Liu et al.
CELL DEATH & DISEASE (2020)
Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease
Fatemeh Abbasi et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2020)
Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease
Abbas Shapouri Moghaddam et al.
ATHEROSCLEROSIS (2019)
Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte
Juan Jin et al.
STEM CELL RESEARCH & THERAPY (2019)
Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
Ying Yang et al.
CLINICAL NEPHROLOGY (2019)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
Yihua Bai et al.
MEDICAL SCIENCE MONITOR (2019)
Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Sadayoshi Ito et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Impact of ET-1 and sex in glomerular hyperfiltration in humanized sickle cell mice
Malgorzata Kasztan et al.
CLINICAL SCIENCE (2019)
The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy
Hyoungnae Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease
Jinnan Zang et al.
SCIENTIFIC REPORTS (2019)
The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: Opening the way for exosomes based therapeutics
Davod Jafari et al.
BIOCHIMIE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
New pharmacological strategies for protecting kidney function in type 2 diabetes
Marcel H. A. Muskiet et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model
Xingxing An et al.
STEM CELL RESEARCH & THERAPY (2019)
Expression of exosomal miR-21 and miR-29 in serum of children and adolescents with T1DM and persistent microalbuminuria
Alshaymaa A. Ibrahim et al.
GENE REPORTS (2019)
Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Georgia Kapoula et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy
Cristina Grange et al.
SCIENTIFIC REPORTS (2019)
Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy
Laila Ahmed Rashed et al.
BIOCHEMISTRY AND CELL BIOLOGY (2018)
Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy
Shan Wang et al.
CELL PROLIFERATION (2018)
BMSCs and miR-124a ameliorated diabetic nephropathy via inhibiting notch signalling pathway
Jiping Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The role of cannabinoid signaling in acute and chronic kidney diseases
Federica Barutta et al.
KIDNEY INTERNATIONAL (2018)
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Megan Stevens et al.
GENES (2018)
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R. Tuttle et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy
F. Barutta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells
Kyo Won Lee et al.
JOURNAL OF DIABETES RESEARCH (2018)
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy
Chun-Wu Tung et al.
NEPHROLOGY (2018)
Receptor-Ligand Interaction Mediates Targeting of Endothelial Colony Forming Cell-derived Exosomes to the Kidney after Ischemic Injury
Jose L. Vinas et al.
SCIENTIFIC REPORTS (2018)
Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
Marcel H. A. Muskiet et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway
Nesrine Ebrahim et al.
CELLS (2018)
Novel avenues for treating diabetic nephropathy: new investigational drugs
Viviana Lacava et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Progression of chronic kidney disease: too much cellular talk causes damage
Leslie Gewin et al.
KIDNEY INTERNATIONAL (2017)
Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy
Federica Barutta et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Qidi Ying et al.
RENAL FAILURE (2017)
Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy
Kanna Nagaishi et al.
SCIENTIFIC REPORTS (2017)
Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease
Yijun Xie et al.
JOURNAL OF DIABETES RESEARCH (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
Edgars Endzelins et al.
BMC CANCER (2017)
Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy
Margien G. S. Boels et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
Pascal Bus et al.
DIABETOLOGIA (2017)
Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy
Mixuan Yi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle
Julie Massart et al.
DIABETES (2017)
Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy
Hong Lang et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Clinical verification of a novel urinary microRNA panal: 133b,-342 and-30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis
Sanaa Eissa et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children
Abdelnaby Khalyfa et al.
CHEST (2016)
The Players: Cells Involved in Glomerular Disease
A. Richard Kitching et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
Paul M. Palevsky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
Margien G. S. Boels et al.
DIABETES (2016)
Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models
Yusuke Wada et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan
Hung-Yu Chien et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a
Xiaolei Liang et al.
JOURNAL OF CELL SCIENCE (2016)
Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease
Sanaa Eissa et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
Wim Scheele et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes
Jian-xia Shi et al.
MOLECULAR BIOSYSTEMS (2016)
Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
Bo Wang et al.
MOLECULAR THERAPY (2016)
Nephron Protection in Diabetic Kidney Disease
Hans-Joachim Anders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats
Zhen-zhen Jiang et al.
STEM CELL RESEARCH & THERAPY (2016)
Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study
David K. Packham et al.
EBIOMEDICINE (2016)
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
Xin Mou et al.
PLOS ONE (2016)
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients
Denis Delic et al.
PLOS ONE (2016)
Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats
Aradhana Mohan et al.
PLOS ONE (2016)
Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting
Sara Gallo et al.
PLOS ONE (2016)
Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
Kanna Nagaishi et al.
SCIENTIFIC REPORTS (2016)
Transforming growth factor-β1 and diabetic nephropathy
Albert S. Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease
LuAnn Sabounjian et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2016)
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice
Greg H. Tesch et al.
DIABETES (2015)
AGEs-RAGE System Down-Regulates Sirt1 Through the Ubiquitin-Proteasome Pathway to Promote FN and TGF-beta 1 Expression in Male Rat Glomerular Mesangial Cells
Kai-Peng Huang et al.
ENDOCRINOLOGY (2015)
Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1
Rui Peng et al.
GENE (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Adipose-Derived Mesenchymal Stem Cells Transplantation Alleviates Renal Injury in Streptozotocin-Induced Diabetic Nephropathy
Weimin Ni et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Manjeri A. Venkatachalam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
Helen C. Looker et al.
KIDNEY INTERNATIONAL (2015)
被撤回的出版物: miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer (Retracted article. See vol. 22, 2021)
Yan Hou et al.
ONCOLOGY LETTERS (2015)
Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells
Yan Wang et al.
STEM CELL RESEARCH & THERAPY (2015)
Inflammatory Cytokines in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF DIABETES RESEARCH (2015)
Rs12976445 Polymorphism is Associated with Risk of Diabetic Nephropathy Through Modulating Expression of MicroRNA-125 and Interleukin-6R
Cunjie Li et al.
MEDICAL SCIENCE MONITOR (2015)
Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
Wanfen Zhang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7
Shasha Lv et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress
Shasha Lv et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids
Junnan Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Endothelin and endothelin antagonists in chronic kidney disease
Donald E. Kohan et al.
KIDNEY INTERNATIONAL (2014)
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
Bo Wang et al.
KIDNEY INTERNATIONAL (2014)
Human Urine-Derived Stem Cells Alone or Genetically-Modified with FGF2 Improve Type 2 Diabetic Erectile Dysfunction in a Rat Model
Bin Ouyang et al.
PLOS ONE (2014)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model
Shuai Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models
J. -W. Kim et al.
DIABETOLOGIA (2013)
A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy
Ji Zhou et al.
GENE (2013)
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration
Sha-Sha Lv et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery
Lin-Li Lv et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
Eoin P. Brennan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer
Riccardo Cazzoli et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Federica Barutta et al.
PLOS ONE (2013)
Multipotential Differentiation of Human Urine-Derived Stem Cells: Potential for Therapeutic Applications in Urology
Shantaram Bharadwaj et al.
STEM CELLS (2013)
Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy
Jonathan Fraportti do Nascimento et al.
BMC NEPHROLOGY (2013)
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
Timothy Sullivan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells
Eun-Hee Nam et al.
CARCINOGENESIS (2012)
Early Renal Function Decline in Type 2 Diabetes
Meda E. Pavkov et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
M. Hara et al.
DIABETOLOGIA (2012)
Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression
Lotte B. Nielsen et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro
Xiao-Ming Meng et al.
JOURNAL OF PATHOLOGY (2012)
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Tomohito Gohda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Monika A. Niewczas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
Alessia Gallo et al.
PLOS ONE (2012)
Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion
Jae-Hyung Chang et al.
PLOS ONE (2012)
Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study
Belinda Jim et al.
PLOS ONE (2012)
Endothelin-1 and Endothelin A Receptor Immunoreactivity Is Increased in Patients with Diabetic Nephropathy
Claudete Maria Zanatta et al.
RENAL FAILURE (2012)
Horizontal transfer of RNAs: exosomes as mediators of intercellular communication
Saraswathi Ramachandran et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
Lei Kong et al.
ACTA DIABETOLOGICA (2011)
Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
Ferdau L. Nauta et al.
DIABETES CARE (2011)
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Markus Goedel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Autologous Transplantation of Adipose-Derived Mesenchymal Stem Cells Markedly Reduced Acute Ischemia-Reperfusion Lung Injury in a Rodent Model
Cheuk-Kwan Sun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lasser et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Nephrinuria associates with multiple renal traits in type 2 diabetes
Daniel P. K. Ng et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Endothelin-1 and diabetic complications: Focus on the vasculature
Adviye Ergul
PHARMACOLOGICAL RESEARCH (2011)
The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions
Abdoljalal Marjani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2011)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Richard J. Glassock
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy
Chia-Chao Wu et al.
CLINICA CHIMICA ACTA (2010)
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
A. M. D. Watson et al.
DIABETOLOGIA (2010)
RAGE and the pathogenesis of chronic kidney disease
Vivette D'Agati et al.
NATURE REVIEWS NEPHROLOGY (2010)
Serum Concentrations of Markers of TNF alpha and Fas-Mediated Pathways and Renal Function in Nonproteinuric Patients with Type 1 Diabetes
Monika A. Niewczas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effect of pentoxifylline on the evolution of diabetic nephropathy
Rafael Leyva-Jimenez et al.
MEDICINA CLINICA (2009)
In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-β1
Jasimuddin Ahamed et al.
PLOS ONE (2009)
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage
Davide Bolignano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Podocyte-Specific Deletion of Dicer Alters Cytoskeletal Dynamics and Causes Glomerular Disease
Scott J. Harvey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease
Peasad Devarajan
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism
Jennifer M. Sasser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy
Gang Wang et al.
NEPHRON CLINICAL PRACTICE (2007)
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients
Juan F. Navarro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Integrin signaling is critical for pathological angiogenesis
Ganapati H. Mahabeleshwar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli
NA Wahab et al.
DIABETOLOGIA (2005)
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
J Mishra et al.
LANCET (2005)
Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo
C Daniel et al.
KIDNEY INTERNATIONAL (2004)
Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor β-independent pathway
GH Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans
G Ahlborg et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
J Comijn et al.
MOLECULAR CELL (2001)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
Share Paper
